Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 3
1991 3
1992 1
1994 1
1997 1
2001 1
2002 1
2003 3
2004 2
2005 1
2006 4
2007 5
2008 3
2009 4
2010 2
2011 5
2012 2
2013 1
2014 2
2017 2
2019 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Results by year
Filters applied: . Clear all
Page 1
Prognostic value of chemotherapy-resistant CK19mRNA-positive circulating tumor cells in patients with advanced/metastatic non-small cell lung cancer.
Milaki G, Messaritakis I, Koinis F, Kotsakis A, Apostolaki S, Dermitzaki EK, Perraki M, Hatzidaki D, Georgoulias V. Milaki G, et al. Among authors: perraki m. Cancer Chemother Pharmacol. 2017 Jul;80(1):101-108. doi: 10.1007/s00280-017-3339-0. Epub 2017 May 18. Cancer Chemother Pharmacol. 2017. PMID: 28523597
A Comparison of Three Methods for the Detection of Circulating Tumor Cells in Patients with Early and Metastatic Breast Cancer.
Politaki E, Agelaki S, Apostolaki S, Hatzidaki D, Strati A, Koinis F, Perraki M, Saloustrou G, Stoupis G, Kallergi G, Spiliotaki M, Skaltsi T, Lianidou E, Georgoulias V, Mavroudis D. Politaki E, et al. Among authors: perraki m. Cell Physiol Biochem. 2017;44(2):594-606. doi: 10.1159/000485115. Epub 2017 Nov 20. Cell Physiol Biochem. 2017. PMID: 29161698 Free article.
Effect of front-line chemotherapy on circulating CK-19 mRNA-positive cells in patients with metastatic breast cancer.
Georgoulias V, Apostolaki S, Bozionelou V, Politaki E, Perraki M, Georgoulia N, Kalbakis K, Kotsakis A, Xyrafas A, Agelaki S, Mavroudis D. Georgoulias V, et al. Among authors: perraki m. Cancer Chemother Pharmacol. 2014 Dec;74(6):1217-25. doi: 10.1007/s00280-014-2598-2. Epub 2014 Oct 26. Cancer Chemother Pharmacol. 2014. PMID: 25344760 Clinical Trial.
Brown diamonds from an eclogite xenolith from Udachnaya kimberlite, Yakutia, Russia.
Stepanov AS, Korsakov AV, Yuryeva OP, Nadolinniy VA, Perraki M, De Gussem K, Vandenabeele P. Stepanov AS, et al. Among authors: perraki m. Spectrochim Acta A Mol Biomol Spectrosc. 2011 Oct;80(1):41-8. doi: 10.1016/j.saa.2011.01.006. Epub 2011 Jan 13. Spectrochim Acta A Mol Biomol Spectrosc. 2011. PMID: 21324732
Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer.
Xenidis N, Perraki M, Apostolaki S, Agelaki S, Kalbakis K, Vardakis N, Kalykaki A, Xyrafas A, Kakolyris S, Mavroudis D, Georgoulias V. Xenidis N, et al. Among authors: perraki m. Br J Cancer. 2013 Feb 19;108(3):549-56. doi: 10.1038/bjc.2012.597. Epub 2013 Jan 17. Br J Cancer. 2013. PMID: 23329233 Free PMC article.
Detection of circulating cytokeratin-19 mRNA-positive cells in the blood and the mitotic index of the primary tumor have independent prognostic value in early breast cancer.
Tryfonidis K, Kafousi M, Perraki M, Apostolaki S, Agelaki S, Georgoulias V, Stathopoulos E, Mavroudis D. Tryfonidis K, et al. Among authors: perraki m. Clin Breast Cancer. 2014 Dec;14(6):442-50. doi: 10.1016/j.clbc.2014.04.001. Epub 2014 Jun 2. Clin Breast Cancer. 2014. PMID: 24958324
45 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page